These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 30298621

  • 1. Switching the manufacturer of antiepileptic drugs is associated with higher risk of seizures: A nationwide study of prescription data in Germany.
    Lang JD, Kostev K, Onugoren MD, Gollwitzer S, Graf W, Müller T, Olmes DG, Hamer HM.
    Ann Neurol; 2018 Dec; 84(6):918-925. PubMed ID: 30298621
    [Abstract] [Full Text] [Related]

  • 2. Manufacturer switch of anti-seizure drugs may not increase the risk of seizure recurrence in Children: A nationwide study of prescription data in Germany.
    Lang JD, Kostev K, Reindl C, Mueller TM, Stritzelberger J, Gollwitzer S, Westermayer V, Trollmann R, Hamer HM.
    Epilepsy Behav; 2021 Feb; 115():107705. PubMed ID: 33444987
    [Abstract] [Full Text] [Related]

  • 3. Switching generic antiepileptic drug manufacturer not linked to seizures: A case-crossover study.
    Kesselheim AS, Bykov K, Gagne JJ, Wang SV, Choudhry NK.
    Neurology; 2016 Oct 25; 87(17):1796-1801. PubMed ID: 27683844
    [Abstract] [Full Text] [Related]

  • 4. Bioequivalent antiepileptic drug switching and the risk of seizure-related events.
    Hansen RN, Nguyen HP, Sullivan SD.
    Epilepsy Res; 2013 Sep 25; 106(1-2):237-43. PubMed ID: 23726541
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Impact of generic substitution on levetiracetam serum concentration-A prospective study in an outpatient setting.
    Reimers A, Olsson P, Nilsson J, Hoff E, Reis M, Strandberg M, Lundgren A, Källén K.
    Epilepsy Res; 2017 Aug 25; 134():54-61. PubMed ID: 28595756
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of generic switching on concerns about medicine and non-persistence among Danish adults in a general practice setting.
    Rathe JØ.
    Dan Med J; 2015 Oct 25; 62(10):B5148. PubMed ID: 26441397
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Exploring generic brittleness and the demographic factors for its susceptibility in patients with epilepsy.
    Das S, Pu X, Jiang X, Jiang W, Tung R, Ting TY, Polli JE.
    Epilepsy Behav; 2019 Jan 25; 90():197-203. PubMed ID: 30579779
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Generic substitution of antiepileptic drugs--a survey of patients' perspectives in Germany and other German-speaking countries.
    Hensler K, Uhlmann C, Porschen T, Benecke R, Rösche J.
    Epilepsy Behav; 2013 Apr 25; 27(1):135-9. PubMed ID: 23416284
    [Abstract] [Full Text] [Related]

  • 17. Generic lamotrigine versus brand-name Lamictal bioequivalence in patients with epilepsy: A field test of the FDA bioequivalence standard.
    Ting TY, Jiang W, Lionberger R, Wong J, Jones JW, Kane MA, Krumholz A, Temple R, Polli JE.
    Epilepsia; 2015 Sep 25; 56(9):1415-24. PubMed ID: 26201987
    [Abstract] [Full Text] [Related]

  • 18. Identification of adverse reactions that can occur on substitution of generic for branded lamotrigine in patients with epilepsy.
    Makus KG, McCormick J.
    Clin Ther; 2007 Feb 25; 29(2):334-41. PubMed ID: 17472825
    [Abstract] [Full Text] [Related]

  • 19. Sociodemographic disparities in administration of antiepileptic drugs to adults with epilepsy in Germany: a retrospective, database study of drug prescriptions.
    Hamer HM, Kostev K.
    CNS Drugs; 2014 Aug 25; 28(8):753-9. PubMed ID: 25005594
    [Abstract] [Full Text] [Related]

  • 20. Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy: The EQUIGEN Randomized Clinical Trial.
    Berg M, Welty TE, Gidal BE, Diaz FJ, Krebill R, Szaflarski JP, Dworetzky BA, Pollard JR, Elder EJ, Jiang W, Jiang X, Switzer RD, Privitera MD.
    JAMA Neurol; 2017 Aug 01; 74(8):919-926. PubMed ID: 28654954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.